Abstract
Objective
The objective was to compare the short- and long-term impact of 3 different treatment modalities on health-related quality of life (HRQOL) in patients treated for localised prostate cancer at a single centre in Catalonia, Spain.
Material and methods
This was a longitudinal, prospective study of 304 patients from a single centre in Catalonia, Spain. Patients underwent 1 of 3 treatment procedures: radical prostatectomy (114 patients), external beam radiation (134) or interstitial brachytherapy (56). HRQOL was assessed by both general and specific questionnaires, including the SF-36 health survey and the Expanded Prostate Cancer Index Composite (EPIC). Interviews were administered prior to treatment and at months 1, 3, 6, 12 and 24. One-way analysis of variance and generalised estimating equations models were constructed to assess between-group differences in HRQOL.
Results
After initial deterioration, HRQOL scores partially recovered, although significant differences between treatment groups persisted at two years. Worsening of urinary incontinence was especially marked for the radical prostatectomy group (11.45, p=0.005), while deterioration in the urinary irritative/obstructive domain was worse following brachytherapy treatment (4.76, p=0.025). Decline in sexual function was significantly greater for the radical prostatectomy group than for the brachytherapy group (18.74, p<0.001). No significant between-group differences were observed in bowel domain scores.
Conclusions
Quality of life 2 years after treatment for prostate cancer shows wide variability. Radical prostatectomy had the largest negative impact on the sexual and urinary incontinence domains. Differences between external radiation and brachytherapy were relatively small. Brachytherapy led to a moderate increase in urinary irritation compared to the other 2 groups.
Similar content being viewed by others
References
Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80
Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101
Draisma G, Boer R, Otto SJ et al (2003) Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95:868–878
Peschel RE, Colberg JW (2003) Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 4:233–241
Chun FK, Graefen M, Zacharias M et al (2006) Anatomic radical retropubic prostatectomy-longterm recurrence-free survival rates for localized prostate cancer. World J Urol 24:273–280
Bernier J, Hall EJ, Giaccia A (2004) Radiation oncology: a century of achievements. Nat Rev Cancer 4:737–747
D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974
Kupelian PA, Potters L, Khuntia D et al (2004) Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25–33
Potters L, Klein EA, Kattan MW et al (2004) Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71:29–33
Walz C, Joniau S, Salem N et al (2008) A matchedpair analysis between radical prostatectomy and low dose rate brachytherapy in low risk prostate cancer patients. Eur Urol Suppl 7:167 [Abstract]
Bacon CG, Giovannucci E, Testa M, Kawachi I (2001) The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166:1804–1810
Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163:851–857
Burnett AL, Aus G, Canby-Hagino ED et al (2007) Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 178:597–601
Buron C, Le Vu B, Cosset JM et al (2007) Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys 67:812–822
Dandapani SV, Sanda MG (2008) Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer. Semin Radiat Oncol 18:67–72
Davis JW, Kuban DA, Lynch DF, Schellhammer PF (2001) Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 166:947–952
Ferrer M, Suarez JF, Guedea F et al (2008) Healthrelated quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72:421–432
Frank SJ, Pisters LL, Davis J et al (2007) An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177:2151–2156
McCammon KA, Kolm P, Main B, Schellhammer PF (1999) Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 54:509–516
Mols F, van de Poll-Franse LV, Vingerhoets AJ et al (2006) Long-term quality of life among Dutch prostate cancer survivors: results of a populationbased study. Cancer 107:2186–2196
Namiki S, Satoh T, Baba S et al (2006) Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology 68:1230–1236
Newton F, Millar JL, Burney S et al (2008) Characterization of the pattern of sexual function after brachytherapy or radical prostatectomy suggests the importance of expectation management. Brachytherapy 7:121 [Abstract]
Pinkawa M, Fischedick K, Piroth MD et al (2006) Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters. Strahlenther Onkol 182:660–665
Saito S, Nagata H, Kosugi M et al (2008) Comparison of health related quality of life after the treatment of prostate cancer with permanent seed implantation brachytherapy and radical prostatectomy. Brachytherapy 7:121 [Abstract]
Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250–1261
Suarez JF, Aguilo F, Ferrer M et al (2007) Impact on health-related quality of life of radical prostatectomy and prostate brachytherapy in patients with low and intermediate-risk clinically localized prostate cancer. Eur Urol Suppl 6:54 [Abstract]
Tepera C, Berry T, Schellhammer P et al (2008) Prospective, longitudinal, ongoing study of health related quality of life (QOL) in patients undergoing cryoablation as compared to brachytherapy for localized prostate cancer. J Urol 179:398 [Abstract]
Yoshimura K, Kamoto T, Nakamura E et al (2007) Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy. Prostate Cancer Prostatic Dis 10:288–292
Bice WS Jr, Prestidge BR, Prete JJ, Dubois DF (1998) Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 40:1237–1241
Ware JE, Kosinski M, Dewey JE (2000) How to Score. Version 2 of the SF-36 Health Survey (Standard & Acute Forms). Quality Metric Incorporated, Lincoln, RI
Wei JT, Dunn RL, Litwin MS et al (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899–905
Schostak M, Miller K, Schrader M (2008) Radical prostatectomy in the 21st century — the gold standard for localized and locally advanced prostate cancer. Front Radiat Ther Oncol 41:7–14
Block T, Czempiel H, Zimmermann F (2006) Transperineal permanent seed implantation of “low-risk” prostate cancer: 5-year-experiences in 118 patients. Strahlenther Onkol 182:666–671
Machtens S, Baumann R, Hagemann J et al (2006) Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol 24:289–295
Stock RG, Cesaretti JA, Stone NN (2006) Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys 64:810–816
Trojan L, Harrer K, Bolenz C et al (2008) Longterm functional outcome after treatment of prostate cancer: radical prostatectomy vs. brachytherapy. Eur Urol Suppl 7:168 [Abstract]
Borchers H, Kirschner-Hermanns R, Brehmer B et al (2004) Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. BJU Int 94:805–811
Litwin MS, Gore JL, Kwan L et al (2007) Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 109:2239–2247
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Guedea, F., Ferrer, M., Pera, J. et al. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience. Clin Transl Oncol 11, 470–478 (2009). https://doi.org/10.1007/s12094-009-0387-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-009-0387-x